Rush University Medical Center

Early Predictor of Severe Respiratory Failure in Patients With COVID-19 Identified

Findings published in Critical Care suggest that high plasma levels of the protein suPAR are associated with worse outcomes

Newswise — A very high level of a protein known as suPAR in the blood of patients with COVID-19 may be a predictor of severe respiratory failure, according to new research published in the Journal of Critical Care on April 30. The findings by researchers at Rush University Medical Center and other institutions suggest suPAR could be a potential predictor for which patients with COVID-19 will need to be put on ventilators to help them breathe.

“This is the first report in the world to show that suPAR is elevated in COVID-19 and is predictive. Since suPAR is a reactant of the innate immune system, it’s an indicator of disease severity,” said Jochen Reiser, MD, PhD, the Ralph C. Brown, MD, Professor of Internal Medicine, chairperson of the Department of Internal Medicine at Rush.

“These results show that the higher the plasma suPAR level, the worse the outcome will be in the lungs of these patients,” said Reiser, who is co-correspondent author of the study. “The higher the suPAR level, the shorter the time before patients needed intubation.”

Reiser’s research team tested suPAR levels in 15 Rush patients when they were admitted or tested for COVID-19. The University of Athens Medical School measured 57 patients for suPAR and followed them in their clinical course. Time to intubation was followed and found to be shorter in patients with a higher plasma suPAR.

“There is a body of literature that suPAR is associated with poor outcomes from acute respiratory distress syndrome (a condition in many patients with severe COVID-19) and poor lung functioning in critically ill patients,” Reiser said.

Reiser also mentions that the link between suPAR and respiratory failure suggests a way to help manage patients with COVID-19.

“If we measure suPAR as part of diagnosing COVID-19, we may know whom to watch more and whom to send home,” he said. “Plasma suPAR levels give us a window into the course of the disease, allowing for an improved monitoring and applying new and supportive treatments early.” 

The findings of the present research raise additional new questions about a role for suPAR in COVID-19-associated organ dysfunction.

Soluble urokinase plasminogen activator receptor, aka suPAR, is produced in the endobronchial tree in the lungs and by immune cells in the bone marrow and repeatedly has been shown to harm kidneys. In two publications in The New England Journal of Medicine, Reiser’s research showed that chronically elevated blood levels are linked to development of chronic kidney disease, yet a high plasma suPAR also increases the risk for acute kidney injury – a sudden decline in kidney function that can be a severe side effect of general medical procedures.

Reportedly, an increasing number of patients with severe COVID-19 also develop kidney problems, which is leading researchers to investigate the connection between COVID-19, suPAR and kidney disease.

“Our research on suPAR and COVID-19 associated lung injury is based on a small sample size, and we will need more data, but the findings support a concept that suPAR is harmful in COVID-19. It may therefore play a prognostic and a causal role in COVID-19 associated kidney disease, Reiser said.”

Funding for this work was provided by unrestricted educational grants by the Hellenic Institute for the Study of Sepsis. Funds were also provided by Rush University Medical Center.

 




Filters close

Showing results

1120 of 2581
Newswise: ShortTermDistancing.jpg
Released: 15-Jul-2020 4:10 PM EDT
Social distancing and COVID-19: A law of diminishing returns
Washington University in St. Louis

Modeling from the McKelvey School of Engineering at Washington University in St. Louis shows how social distancing could have better been implemented. The key? Longer periods of distancing would have helped — but only to a point. More needed to be done.

Newswise: About nine family members to suffer grief from every COVID-19 fatality
Released: 15-Jul-2020 3:05 PM EDT
About nine family members to suffer grief from every COVID-19 fatality
Penn State Institute for Computational and Data Sciences

Deaths from COVID-19 will have a ripple effect causing impacts on the mental health and health of surviving family members. But the extent of that impact has been hard to assess until now. Every death from COVID-19 will impact approximately nine surviving family members, according to a study.

Released: 15-Jul-2020 2:45 PM EDT
People with Coronavirus Symptoms More Likely to Have General Psychiatric Disorders and Loneliness
University of Cambridge

People who have or had COVID-19 symptoms are more likely to develop general psychiatric disorders and are lonelier, with women and young people more at risk, says a just-published study co-authored at Cambridge Judge Business School.

Released: 15-Jul-2020 1:10 PM EDT
In one hour, surface coating inactivates virus that causes COVID-19
Virginia Tech

A Virginia Tech chemical engineering professor has developed a surface coating that, when painted on common objects, inactivates SARS-CoV-2, the virus that causes COVID-19.

Released: 15-Jul-2020 1:05 PM EDT
After universal masking, health care worker COVID-19 rates drop at Mass General Brigham
Brigham and Women’s Hospital

In March of 2020, Mass General Brigham implemented a new policy: everyone working at the hospitals would be required to wear a surgical mask.

Newswise: 237522_web.jpg
Released: 15-Jul-2020 12:40 PM EDT
Global sentiments towards COVID-19 shifts from fear to anger
Nanyang Technological University

The fear that people developed at the start of the COVID-19 outbreak has given way to anger over the course of the pandemic, a study of global sentiments led by Nanyang Technological University, Singapore (NTU Singapore) has found.

Newswise: 237488_web.jpg
Released: 15-Jul-2020 12:30 PM EDT
COVID-19 may attack patients' central nervous system
University of Cincinnati

Depressed mood or anxiety exhibited in COVID-19 patients may possibly be a sign the virus affects the central nervous system, according to an international study led by a University of Cincinnati College of Medicine researcher.

Newswise: Common FDA-Approved Drug May Effectively Neutralize Virus That Causes COVID-19
Released: 15-Jul-2020 12:15 PM EDT
Common FDA-Approved Drug May Effectively Neutralize Virus That Causes COVID-19
Rensselaer Polytechnic Institute (RPI)

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

Released: 15-Jul-2020 12:10 PM EDT
Back to the Operating Room: Orthopedic Surgeons Issue Guidelines on Resuming Elective Surgery Amid COVID-19 Pandemic
Wolters Kluwer Health: Lippincott Williams and Wilkins

Since the start of the COVID-19 pandemic, thousands of Americans have had to delay recommended but elective orthopedic surgical procedures, such as joint replacement surgery or knee arthroscopy. Now an expert panel has issued recommendations to guide safe resumption of elective orthopedic surgery. The guidelines appear in the July 15, 2020 issue of The Journal of Bone & Joint Surgery, published in the Lippincott portfolio in partnership with Wolters Kluwer.


Showing results

1120 of 2581

close
1.82985